Clinical trials
Phase 3 Breast Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
259 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 4 |
| 2003 | 3 |
| 2005 | 1 |
| 2006 | 5 |
| 2007 | 5 |
| 2008 | 7 |
| 2009 | 10 |
| 2010 | 5 |
| 2011 | 9 |
| 2012 | 7 |
| 2013 | 8 |
| 2014 | 8 |
| 2015 | 6 |
| 2016 | 12 |
| 2017 | 6 |
| 2018 | 9 |
| 2019 | 10 |
| 2020 | 17 |
| 2021 | 23 |
| 2022 | 19 |
| 2023 | 26 |
| 2024 | 17 |
| 2025 | 29 |
| 2026 | 13 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 75 |
| Completed | 71 |
| Active, not recruiting | 49 |
| Unknown status | 37 |
| Terminated | 15 |
| Not yet recruiting | 9 |
| Withdrawn | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fudan University | 30 |
| Hoffmann-La Roche | 22 |
| AstraZeneca | 19 |
| Sun Yat-sen University | 13 |
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 12 |
| Novartis Pharmaceuticals | 11 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 6 |
| Chinese Academy of Medical Sciences | 6 |
| Eli Lilly and Company | 6 |
| Jiangsu HengRui Medicine Co., Ltd. | 6 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 259 |
| Neoplasm Metastasis | 20 |
| Triple Negative Breast Neoplasms | 13 |
| Neoplasms | 4 |
| Breast Diseases | 3 |
| Nausea | 2 |
| Neoplasms by Site | 2 |
| Neutropenia | 2 |
| Pathologic Complete Response | 2 |
| Radiation Injuries | 2 |
Trials
Showing 1 to 25 of 259. Each trial links to its page on Pharma Observatory.
159 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.